CurrentAetnaPolicy 0263

Gait Analysis and Electrodynogram

Defines Aetna's coverage stance for gait analysis (motion analysis) and electrodynogram (dynamic EMG) including codes considered not covered and background evidence. Applies to gait analysis, dynamic EMG, electrodynogram and wearable running gait devices.

Policy Summary

PayerAetna

PolicyGait Analysis and Electrodynogram

Policy CodePolicy 0263

Change TypeAdministrative review (no material clinical changes)

Effective Date

Next Review Date03/14/2024

Key ActionClaims for CPT codes 96000-96004, HCPCS wearable gait analysis devices, and listed ICD-10 indications are considered experimental/investigational and are not covered; providers should expect denial and document medical necessity if attempting appeal.

SourceLink

POLICY UPDATE CHANGES

Last review date recorded as 05/04/2023; next review scheduled for 03/14/2024.

4Procedures experimental/investigational

5Code groups referenced

multipleEvidence sources

small–moderateStudy sizes

CP, THA, LSS, ITWClinical contexts

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Summary

Scope: This policy addresses Aetna's stance on instrumented gait analysis and electrodynogram (dynamic EMG), including laboratory-based motion analysis and wearable running gait devices. The policy classifies gait analysis (motion analysis studies), dynamic electromyography, electrodynogram, and wearable devices for running gait analysis as procedures considered experimental and investigational because their effectiveness has not been established.

Coverage summary: CPT codes 96000–96004, HCPCS codes for wearable running gait devices (no specific code listed), and listed ICD-10 indications (examples: G80.0–G80.9, G82.20–G83.9, R26.0–R26.9, R27.0–R27.9) are included in the Coding section and are considered not covered for the indications in this Clinical Policy Bulletin.

Key brief statistics (brief → policy)

Procedures listed as experimental/investigational4

Code groups referenced5

Evidence sources summarizedmultiple studies

Clinical populations discussedCP, THA, spina bifida, HGS, LSS, ITW, FD, elderly LTC, running

Medical Necessity / Experimental Criteria

Experimental and Investigational

The following procedures are considered experimental and investigational because the effectiveness of these approaches has not been established:

Experimental/Investigational - Not Covered

Gait analysis (also known as motion analysis studies) for conditions that result in gait deviations and for all other indications
Dynamic electromyography for all indications
Use of electrodynogram for all indications
Wearable devices for running gait analysis

Coding (CPT / HCPCS / ICD-10)

CPT codes not covered for indications listed in the CPBCPTNot Covered

96000	Comprehensive computer-based motion analysis by video-taping and 3-D kinematics.
96001	with dynamic plantar pressure measurements during walking.
96002	Dynamic surface electromyography, during walking or other functional activities, 1 - 12 muscles.
96003	Dynamic fine wire electromyography, during walking or other functional activities, 1 muscle.
96004	Review and interpretation by physician or other qualified health care professional of comprehensive computer-based motion analysis, dynamic plantar pressure measurements, dynamic surface electromyography during walking or other functional activities, and dynamic fine wire electromyography, with written report.

HCPCS codes not covered if selection criteria are metHCPCSNot Covered

no_specific_code_listed

Wearable devices for running gait analysis - no specific code

ICD-10 codes not covered for indications listed in the CPB (not all-inclusive)ICD-10Not Covered

G80.0-G80.9	Cerebral palsy
G82.20-G83.9	Paraplegia, quadriplegia and other specified paralytic syndromes
R26.0-R26.9	Abnormality of gait and mobility
R27.0-R27.9	Other lack of coordination

Provider Actions & Billing Impact

Denial Risk

Coverage denial risk for gait analysis and dynamic EMG

Claims for the listed CPT and HCPCS codes and for services provided for the ICD‑10 indications shown in the CPB are considered experimental/investigational and are not covered. Providers should expect claim denials for these services; if appealing, document medical necessity thoroughly and refer to the full policy for rationale and evidence.

CPT codes: 96000, 96001, 96002, 96003, 96004
HCPCS: wearable devices for running gait analysis (no specific HCPCS code listed)
Example ICD-10 groups: G80.0–G80.9 (cerebral palsy); G82.20–G83.9 (paraplegia, quadriplegia and other paralytic syndromes); R26.0–R26.9 (abnormality of gait and mobility); R27.0–R27.9 (other lack of coordination)

Documentation Required

Policy review and administrative details

Providers should consult the full Clinical Policy Bulletin for the detailed coverage criteria, the complete lists of applicable CPT/HCPCS/ICD-10 codes, and any prior authorization or coding requirements. This callout summarizes administrative references and history only.

Background & Evidence Summary

Background: Instrumented gait analysis (including 3-D instrumented motion analysis and dynamic EMG) has been shown in multiple studies to change surgical or treatment planning and to increase clinician confidence; however, randomized and well-controlled trials have not consistently demonstrated improved patient-centered clinical outcomes compared with standard clinical or observational gait assessments.

Limitations: The evidence is limited by small sample sizes, retrospective designs in many studies, heterogeneity of technical parameters (marker models, cameras, force plates, EMG use), variability in interpretation across centers, and limited generalizability of findings.

Policy conclusion: Because effectiveness for improving clinical outcomes has not been established, instrumented gait analysis, dynamic EMG/electrodynogram, and wearable running gait devices are considered experimental and investigational for the indications listed in this policy.

Evidence	Key Finding
Wren et al. 2013 (RCT)	Randomized trial in 156 ambulatory children with cerebral palsy: no significant differences in primary outcomes (FAQ, GDI, O2 cost); some secondary HRQOL components improved; surgeons followed gait-report recommendations <50% of the time.
Rasmussen et al. 2019 (RCT)	Randomized trial in 60 children with CP (GMFCS I-II): interventions based on gait analysis were not superior to usual care on gait, walking, or patient-reported outcomes; low compliance with recommended interventions noted.
Wren et al. 2020 (systematic review)	Updated systematic review: thousands of studies; 3DGA often changes treatment plans and clinician confidence; limited high-quality evidence—patient outcome improvements seen mainly when recommendations were followed; overall evidence strength mainly III-b.
BlueCross BlueShield TEC 2002	Technology evaluation concluded evidence did not permit conclusions that gait analysis improves outcomes in children with cerebral palsy; lack of well‑designed comparative trials noted.
KneeKG (Knee kinesiography) RCT / review	KneeKG technical accuracy reported (e.g., ~0.4° ab/adduction); a 6-month cluster RCT (n≈515) showed modest improvements in KOOS overall and subscales versus control when KneeKG was added to primary care management.
Wearables – LSS systematic review	Systematic review of wearable devices for lumbar spinal stenosis (4 studies): wearables detected decreased step length and gait velocity versus controls; limited data but potential for objective metrics.
Wearables for running (systematic review)	Systematic review (131 studies): IMUs/accelerometers and pressure sensors generally valid and reliable compared with laboratory standards; most studies small and treadmill-based; heterogeneity in methods.

Glossary — key definitions:

Gait analysis (GA): Systematic evaluation of the dynamics of gait; the standard method is observational assessment without computer programs; instrumented/3-D analyses involve video, kinematics, force plates and may include EMG.

Dynamic electromyography (dynamic EMG): Electromyography collected during walking or other functional activities (surface or fine-wire) to analyze muscle activation patterns.

Electrodynogram: Term used in this policy to refer to dynamic EMG/related instrumented assessments.

3-DGA: Three-dimensional instrumented gait analysis using motion capture systems to quantify kinematics, kinetics, and spatio-temporal parameters.

Revision History

05/04/2023administrative reviewLatest

Last review date recorded as 05/04/2023; next review scheduled for 03/14/2024.